focus -WSS

focus

author：hotspot 2025-09-03 03:43:55 - browse：2784

Scientist Nour Tabidi prepares a DNA sample in a lab. -- health coverage from STAT — Scientist Nour Tabidi prepares a DNA sample in a lab at Thermo Fisher's recently opened manufacturing plant in Plainville. John Tlumacki/Globe Staff

Thermo Fisher Scientific’s giant plant to manufacture gene therapies for drug companies is barely a year old, but executives at the maker of scientific tools are already talking about expanding.

Standing inside a cavernous unfinished section of the plant, Paul Fitzgerald, vice president and general manager of the site, told a group of biotech executives, journalists, and other visitors that he’s eager to transform it into laboratories. So far, the company is only using about 290,000 of the plant’s more than 400,000 square feet.

“I look forward to you guys giving us a reason to fill up this space,” Fitzgerald quipped during a tour Tuesday of the plant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Achieving telehealth equity for people with hearing loss

explore

leisure time

WSS

Unmasking the 'centricity' illusion in clinical trials

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Louisiana bill approved classifying abortion pills as controlled substances

Beyond aggravation: Constipation is an American epidemic

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Should insurance cover cosmetic surgery?

explore

focus

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Antibiotic resistance and the global rise in human conflict

Anesthesiologist group: stop taking Ozempic before surgery

3 medical device trends to watch in 2024

How to save PrEP access — and even expand it

Ahead of JPM, here's who's profiting most in health care

Virginia high school admissions case could be legal follow

Lawsuit challenges CMS nursing home minimum staffing rule

Novavax promises a turnaround & Lilly roils the obesity market

Achieving telehealth equity for people with hearing loss

explore

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

The FDA must approve intranasal treatments for anaphylaxis

White House finalizes ITC's import ban of latest Apple Watches

J&J reports mixed data on next

Why psychiatrists like me stop taking insurance

U.K. sequencing study surfaces new findings about tumor DNA

explore

leisure time

knowledge

Wikipedia